AIG
IMDX

American International Group’s Insight Molecular Diagnostics IMDX Stock Holding History

American International Group’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,494
Closed -$45K – 3213
2022
Q1 		$45K Sell
1,494
-105
-7% -$3.36K ﹤0.01% 2882
2021
Q4 		$69K Sell
1,599
-48
-3% -$2.76K ﹤0.01% 2859
2021
Q3 		$117K Sell
1,647
-338
-17% -$31.1K ﹤0.01% 2733
2021
Q2 		$228 Sell
1,985
-92
-4% -$8.98K ﹤0.01% 2427
2021
Q1 		$216 Buy
2,077
+249
+14% +$23.6K ﹤0.01% 2332
2020
Q4 		$87 Sell
1,828
-53
-3% -$1.94K ﹤0.01% 2731
2020
Q3 		$52K Buy
1,881
+558
+42% +$16K ﹤0.01% 2870
2020
Q2 		$51K Buy
1,323
+661
+100% +$34.1K ﹤0.01% 2875
2020
Q1 		$32K Sell
662
-11
-2% -$539 ﹤0.01% 2830
2019
Q4 		$30K Sell
673
-6
-0.9% -$216 ﹤0.01% 2978
2019
Q3 		$29K Sell
679
-4
-0.6% -$157 ﹤0.01% 2983
2019
Q2 		$34K Buy
+683
New +$56.8K ﹤0.01% 3011
2018
Q2 		– Sell
-123
Closed -$5K – 3103
2018
Q1 		$5K Sell
123
-6
-5% -$396 ﹤0.01% 3019
2017
Q4 		$12K Buy
129
+8
+7% +$902 ﹤0.01% 3025
2017
Q3 		$18K Buy
121
+9
+8% +$943 ﹤0.01% 2831
2017
Q2 		$12K Buy
+112
New +$12.7K ﹤0.01% 3064
2016
Q2 		– Sell
-76
Closed -$7K – 3984
2016
Q1 		$7K Buy
+76
New +$6.73K ﹤0.01% 4654

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

American International Group's IMDX Position: Q2 2022 in Review

American International Group sold out of Insight Molecular Diagnostics (IMDX) in Q2 2022, closing a stake of 1,494 shares — an estimated $45K sold.

American International Group first reported a position in IMDX in Q1 2016 and held it in 17 quarters. The position peaked at $117K in Q3 2021. 75 funds tracked by Wall St. Rank hold IMDX as of Q2 2022.

  • American International Group reported no remaining Insight Molecular Diagnostics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 1,494 Insight Molecular Diagnostics shares in Q2 2022, an estimated $45K.
  • American International Group first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 17 quarters.
  • American International Group's Insight Molecular Diagnostics position peaked at $117K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.